Liu et al. [130] revealed that triple-negative breast cancer (TNBC)-derived EVs could transfer EphA2 protein to endothelial cells to enhance vascular permeability by downregulating ZO-1 and activating the RhoA pathway in endothelial cells, thus promoting tumor cell metastasis. The gene discussed is TJP1; the disease is neoplasm.